The Clinical Experience of the Bladder Augmentation with Goodwin's Ileal Cup-patched Bladder.
- Author:
Joong Shik LEE
1
;
Sang Yol MAH
Author Information
1. Department of Urology, Yongdong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. mahsy@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Bladder;
Neurogenic bladder;
Treatment
- MeSH:
Compliance;
Follow-Up Studies;
Humans;
Reoperation;
Urinalysis;
Urinary Bladder*;
Urinary Bladder, Neurogenic;
Urodynamics;
Vesico-Ureteral Reflux
- From:Korean Journal of Urology
2003;44(9):882-888
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Augmentation enterocystoplasty is a valuable technique, as a surgical repertoire, for urologists treating a myriad of conditions that cause either a small anatomic or functional bladder capacity. A variety of surgical techniques for augmentation cystoplasty have been developed. The clinical availability of augmentation cystoplasty was evaluated using a Goodwin's ileal cup-patched bladder in patients with a small capacity, high pressure, poorly compliant and unstable bladder. MATERIALS AND METHODS: At our institute, 21 patients, with a neurogenic bladder, have undergone augmentation cystoplasty using a Goodwin's ileal cup-patched bladder, since July 1999. The mean age at operation and follow-up period were 32 years and 11 months, respectively. 9 patients had various degrees of vesicoureteral reflux. The preoperative assessments included urinalysis, urine culture, renal function tests, voiding cystourethrography and urodynamic evaluation. RESULTS: The mean bladder capacity increased from 170cc preoperatively to 438cc postoperatively. The mean maximal end-filling intravesical pressure decreased from 55cmH2O to 22cmH2O, with a significant increase in bladder compliance. There were no significant complications that required surgical revision. CONCLUSIONS: Augmentation cystoplasty using a Goodwin's ileal cup-patched bladder offers a high success rate, with low complications, in selected patients with neurogenic bladder dysfunction.
